CDC: Decrease in Maternal Mortality Rates Seen in 2022
By Elana Gotkine HealthDay Reporter
THURSDAY, May 2, 2024 -- In 2022, there was a decrease in maternal mortality rates, according to a report published in the May Health E-Stats, a publication of the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
Donna L. Hoyert, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, examined maternal mortality rates for 2022 using data from the National Vital Statistics System based on age group and race and Hispanic origin.
Hoyert found that 817 women died of maternal causes in the United States in 2022 compared with 1,205 in 2021, 861 in 2020, 754 in 2019, and 658 in 2018. There was a decrease in the maternal mortality rate, from 32.9 deaths per 100,000 livebirths in 2021 to 22.3 deaths in 2022. Maternal mortality rates decreased significantly for Black non-Hispanic, White non-Hispanic, and Hispanic women in 2022; for Asian non-Hispanic women, the decrease was not statistically significant. In 2022, the maternal mortality rate was 49.5 deaths per 100,000 live births for Black women compared with 19.0, 16.9, and 13.2 for White, Hispanic, and Asian women, respectively.
From 2021 to 2022, there was a significant decrease in rates for each age group; the rates in 2022 were 14.4, 21.1, and 87.1 deaths per 100,000 live births for those aged younger than 25 years, ages 25 to 39 years, and age 40 years or older, respectively. Women aged 40 years and older had a sixfold higher mortality rate than women aged younger than 25 years.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2024
Read this next
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
TUESDAY, April 29, 2025 -- Patients with cancer aged 65 years and older receiving immune checkpoint inhibitors (ICIs) derive similar clinical outcomes as younger patients...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.